Autres langues Dancann Pharma A/S

Actions

DANCAN

DK0061410487

Cours en clôture NORDIC GROWTH MARKET Autres places de cotation 00:00:00 29/04/2024			Varia. 5j.	Varia. 1 janv.
0,06 ^DKK	+7,14%		+40,19%	+100,00%

29/03	Dancann Pharma prévoit une émission de droits d'un montant maximal de 19 millions de couronnes danoises	MT
28/02	DanCann Pharma prend acte de la légalisation du cannabis en Allemagne et ses actions montent en flèche	MT

Autres langues

Débloquez toutes les actualités sur toutes les entreprises : Ne manquez plus une opportunité d'investissement rentable !

Inscription 100% Gratuite

DanCann Pharma A/S: MINUTES OF EXTRAORDINARY GENERAL MEETING	17/04
NOTICE OF EXTRAORDINARY GENERAL MEETING IN DANCANN PHARMA A/S	02/04
Dancann Pharma Plans Up to DKK19 Million Rights Issue	29/03
DanCann Pharma A/S intends to initiate and complete a partly secured rights issue of up to DKK 18.5 million to restructure, strengthen and secure a debt-free capital structure	29/03
DanCann Pharma Notes Cannabis Legalization in Germany as Shares Surge	28/02
DanCann Pharma A/S: Germany makes historic move towards cannabis reclassification and legalization	28/02
DanCann Pharma A/S Reports Fourth Quarter and Full Year 2023 Results	28/02
Dancann Pharma A/S Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	28/02
Dancann Pharma A/S Reports Earnings Results for the Full Year Ended December 31, 2023	28/02
DanCann Pharma A/S Completes Issuance (8) of New Shares from Debt Conversion under the 10-Year Financing Loan-Agreement with 12-months Conversion Option with Nordic Growth Opportunities 2	10/01
DanCann Pharma A/S delivers annual shareholder letter and investor update	20/12
Dancann Pharma A/S Provides Revenue Guidance for the Financial Year 2025	20/12
DanCann Pharma A/S: Flagging announcement	30/11
DanCann Pharma A/S publishes Q3-2023 report	30/11
Dancann Pharma A/S Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	30/11
DanCann Pharma A/S Completes Issuance (7) of New Shares under the Loan-Agreement with Nordic Growth Opportunities 2 - Marking a Milestone with a Conversion Rate Exceeding 50 percent of Tranche 1	28/11
DanCann Pharma Issues New Shares For Debt Conversion	23/11
DanCann Pharma A/S Completes Issuance (6) of New Shares from Debt Conversion under the 10-Year Financing Loan-Agreement with 12-months Conversion Option with Nordic Growth Opportunities 2	22/11
DanCann Pharma A/S: Future strategic direction	26/10/23
DanCann Pharma Issues New Shares Following Debt Conversion	04/10/23

Aucun résultat pour cette recherche

Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Autres langues Dancann Pharma A/S

Actions

DANCAN

DK0061410487

Autres langues

Filtres